Brief: Kimia Biosciences Says Got India Drug Regulator Nod To Manufacture Bilastine
16/03/2021 06:18
March 16 (Reuters) - Kimia Biosciences Ltd KIMI.BO :
* KIMIA BIOSCIENCES - GOT INDIA DRUG REGULATOR NOD TO
MANUFACTURE
NEW API FOR SALE OR FOR DISTRIBUTION' NAMELY BILASTINE
Source text for Eikon: ID:nBSE767V1X
Further company coverage: KIMI.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kimia Biosciences
See all newsBrief: Kimia Biosciences Ltd Says Naveen Sharma Resigns As CFO
Brief: Kimia Biosciences Appoints Naveen Sharma As CFO
Brief: Kimia Biosciences Pradip Kumar Sharma Resigns as Chief Financial Officer
Brief: Kimia Biosciences Says Rakesh Chetani Resigns As CFO
Brief: Kimia Biosciences Gets Order Worth $200,000